News
Kuvandudza Kubudirira kwePROTAC: Chidzidzo Chinoputsa
Ongororo ichangoburwa muNature Communications inoratidza nzwisiso yakakosha mukati memukati mekusaina nzira dzinogadzirisa kushanda kwekwakanangwa kuderedzwa kweprotein uchishandisa PROTACs. Kuwanikwa uku kunogona kugadzira nzira yekurapa kwakanyanya kwegomarara nezvimwe zvirwere.
Kukurudzira Hutano uye Kupora: Kuchengeta Kwezuva Nezuva Kwevarwere veLeukemia
Kuve nechokwadi chekuchengetedza uye kugadzika chiitiko chekurapa kwevarwere veleukemia kunosanganisira kungwarira kwezuva nezuva, kusanganisira hutsanana kwezvakatipoteredza, hutsanana hwemunhu, chikafu, uye kurovedza muviri kwakakodzera. Gwaro iri rinopa matipi akakosha ekutarisira kwakanaka kwezuva nezuva kutsigira kupora.
NS7CAR-T Cell Therapy Inoratidza Vimbiso Yekurapa R/R T-ALL/LBL
Ongororo ichangoburwa inoratidza kushanda nekuchengetedzeka kweNS7CAR-T cell therapy mukurapa kudzokororwa kana refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) uye T-cell lymphoblastic lymphoma (R/R T-LBL). Kurapa uku kunopa tariro itsva kune varwere vane hutsinye mhando dzegomarara idzi.
Groundbreaking Mibairo yeCD7-Targeted CAR-T Therapy yeT-ALL neT-LBL
Ongororo ichangoburwa inoratidza mhedzisiro inovimbisa yeCD7-targeted chimeric antigen receptor (CAR) T cell therapy mukurapa varwere vane relapsed kana refractory T-cell acute lymphoblastic leukemia (T-ALL) uye T-cell lymphoblastic lymphoma (T-LBL).
Kuvharidzirwa kwe2024 ASH Musangano Wepagore uye Kuratidzwa
Musangano Wepagore wechimakumi matanhatu nenhanhatu weAmerican Society of Hematology (ASH) uchaitwa kubva muna Zvita 7-10, 2024, paSan Diego Convention Center, ichiratidza tsvakiridzo yepasi uye kufambira mberi muhematology.
Kuzivisa iyo 2024 Yegore Lu Daopei Hematology Forum muna Nyamavhuvhu
Musangano wechigumi nembiri weLu Daopei Hematology Forum wakarongwa kuti uitwe muna Nyamavhuvhu 23-24, 2024, paBeijing International Convention Center. Joinha isu panhaurirano dzine hungwaru uye kufambira mberi kwazvino muhematology.
Tariro Itsva muCancer Kurapa: TILs Therapy Inobuda seInotevera Frontier
Pasinei nematambudziko arikuenderera mberi mumaindasitiri nekutengeserana, zvipimo zveCAR-T kurapwa zviri kugadziriswa nenzira itsva inovimbisa: Tumor-Infiltrating Lymphocyte (TIL) therapy. Kubudirira uku kunozivisa nguva itsva mukurwisa mamota akasimba.
Ko Maserura Therapies Ndiwo Remangwana reAutoimmune Disease?
Kurapa kwechimurenga kwegomarara kunogona zvakare kurapa nekugadzirisa zvakare immune system kuti ipe kuregererwa kwenguva refu kana kurapa zvimwe zvirwere zve autoimmune.